What are the core principles of antibiotic stewardship in hospital practice?

Study for the Medical Council of Canada Qualifying Examination (MCCQE) I. Engage with flashcards and multiple-choice questions with detailed feedback. Prepare confidently!

Multiple Choice

What are the core principles of antibiotic stewardship in hospital practice?

Antibiotic stewardship in hospital practice aims to optimize antimicrobial use to treat infection effectively while minimizing harm and resistance. The main actions include choosing the narrowest spectrum that will cover the pathogen, obtaining appropriate cultures to identify the organism and its susceptibilities, and then de-escalating to a narrower agent or stopping therapy based on those results and the patient’s clinical response. Therapy should be limited to the shortest duration necessary to treat the infection, avoiding unnecessary continuation and the use of broad-spectrum agents when they aren’t needed. Ongoing monitoring for adverse effects and for emerging resistance is essential to adjust therapy and to track the impact of stewardship efforts. Together, these steps preserve antibiotic effectiveness, reduce toxicity, and help prevent resistant organisms from taking hold. Using broad-spectrum therapy for most infections without de-escalation increases resistance and exposes patients to more adverse effects; not obtaining cultures deprives clinicians of crucial data to guide targeted therapy; and skipping monitoring of adverse events misses early signals that therapy needs adjustment.

Antibiotic stewardship in hospital practice aims to optimize antimicrobial use to treat infection effectively while minimizing harm and resistance. The main actions include choosing the narrowest spectrum that will cover the pathogen, obtaining appropriate cultures to identify the organism and its susceptibilities, and then de-escalating to a narrower agent or stopping therapy based on those results and the patient’s clinical response. Therapy should be limited to the shortest duration necessary to treat the infection, avoiding unnecessary continuation and the use of broad-spectrum agents when they aren’t needed. Ongoing monitoring for adverse effects and for emerging resistance is essential to adjust therapy and to track the impact of stewardship efforts.

Together, these steps preserve antibiotic effectiveness, reduce toxicity, and help prevent resistant organisms from taking hold. Using broad-spectrum therapy for most infections without de-escalation increases resistance and exposes patients to more adverse effects; not obtaining cultures deprives clinicians of crucial data to guide targeted therapy; and skipping monitoring of adverse events misses early signals that therapy needs adjustment.

More practice questions